Monoclonal antibodies binding to FcRn have been developed and have been shown to increase IgG catabolism or have been shown efficacious in ameliorating the symptoms associated with different autoimmune diseases in animal models9,16. This evidence concerns the gene FCGRT and autoimmune disease.